Endo International plc

ISIN IE00BJ3V9050 Symbol ENDP Industry Drug Manufacturers-Specialty & Generic Sector Healthcare
Endo International Price
5.03USD 3.18%
1y Low: 2.7
1y High: 10.7
1y Low: 2.7
1y High: 10.7
Endo International Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
endo.com
Market Cap
1.8 B USD
Dividend Yield
Performance 1y
51.75 %
PER
10.0

Endo International Stock Chart

Endo International Dividend Chart

Endo International Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Endo International Performance

1 Week
1 Month
10.90 %
6 Months
37.77 %
Year to Date
30.61 %
1 Year
51.75 %
5 Years
69.25 %

Endo International Revenue, EBIT, and Income

Endo International Margins

Endo International Shares Outstanding

Useful Links

Search Twitter: $ENDP, #ENDP

Endo International Company Info

Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; TESTOPEL, an implantable pellet indicated for TRT in conditions; EDEX to treat erectile dysfunction; and LIDODERM a topical patch product containing lidocaine. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

Endo International Headquarter

Minerva House, 4 Dublin, Ireland

Endo International Price to Earnings Ratio (PE Ratio): 10.0

The current Price to Earnings Ratio of Endo International is 10.0.
The PE Ratio is calcluated by dividing the current Endo International share price (5.03 USD) by the earnings per share (0.8).

Endo International Market Cap: 1.8 B USD

The current market cap of Endo International is 1.8 B USD.

Endo International Stock Price: 5.03 USD

The current stock price of Endo International is 5.03 USD.

Endo International ISIN: IE00BJ3V9050

The ISIN (International Securities Identification Number) of Endo International is IE00BJ3V9050.

Endo International Ticker Symbol: ENDP

The ticker symbol of Endo International is ENDP.

Endo International Address

The address of the Endo International HQ is Minerva House, 4 Dublin, Ireland.